Download PDF — Appoints James Thorburn as Chief Financial Officer – — Adds Dr. Aaron Sato as Chief Scientific Officer, Pharma — SAN FRANCISCO, Calif. – June 20, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Jim Thorburn as its chief... Read more
Download PDF SAN FRANCISCO, Calif. – June 18, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the expansion of its next-generation sequencing (NGS) solutions product line to include the high throughput Twist Human Core Exome Kit, a library preparation and target enrichment kit, with... Read more
Download PDF SAN FRANCISCO, Calif. – April 18, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that the company has expanded its presence in Asia Pacific, adding strategic distribution partners for synthetic DNA (genes, gene fragment, oligo pool product lines) as well as the... Read more
Download PDF SAN FRANCISCO, Calif. – April 2, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the completion of a private placement of $50 million, bringing the total raised to $259 million since the company’s founding in 2013. “We have used our proprietary DNA... Read more
Download PDF SAN FRANCISCO, Calif. and CARLSBAD, Calif. – February 28, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its North American operations with a new office in the San Diego area. The office will support sales and marketing as... Read more
Download PDF SAN FRANCISCO, Calif. – February 14, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the commercial availability of several new products to enhance next-generation sequencing including its Twist Human Core Exome Kit, an innovative and comprehensive library preparation and target enrichment kit,... Read more
Download PDF November 16, 2017, Oxford, England and San Francisco, Calif. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist... Read more
Download PDF Ginkgo Bioworks and Twist Bioscience Continue to Drive Industry Growth SAN FRANCISCO, Calif. and BOSTON, Mass. – October 3, 2017 – Ginkgo Bioworks, the organism company, and Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA, today announced the expansion of a supply agreement for one billion base pairs... Read more
Download PDF — Iconic Performances of Deep Purple’s “Smoke on the Water”and Miles Davis’ “Tutu” Performed at the Montreux Jazz Festival Stored on DNA for the First Time — San Francisco, CA – September 29, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that, working with Microsoft... Read more
San Francisco, CA – July 11, 2017 – Quintara Biosciences, a leader in DNA sequencing and molecular biology, today announced a new partnership with Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, to launch two new services: qBlock Gene Fragments and qGene DNA cloning. This partnership leverages the high throughput and... Read more